• Home
  • Articles
  • Dr. Eliaz Babaev
  • Michael Afremov
  • Senator Rudy Boschwitz
  • Blake Vanderhyde
  • More
    • Home
    • Articles
    • Dr. Eliaz Babaev
    • Michael Afremov
    • Senator Rudy Boschwitz
    • Blake Vanderhyde
  • Home
  • Articles
  • Dr. Eliaz Babaev
  • Michael Afremov
  • Senator Rudy Boschwitz
  • Blake Vanderhyde

Senator Rudy Boschwitz

Former U.S. Senator and Ambassador

Rudy Boschwitz
Former U.S. Senator and Ambassador 

Advisor to Arobella Medical, LLC


Rudy Boschwitz is a distinguished statesman, diplomat, and humanitarian with decades of leadership in public service and international affairs. A former United States Senator from Minnesota, he also served as U.S. Ambassador to the United Nations Commission on Human Rights.


In 1991, President George H.W. Bush appointed Senator Boschwitz as his special emissary to Ethiopia. His mission led to Operation Solomon, the historic rescue and airlift of Ethiopia’s small Black Jewish community to Israel.


 These negotiations not only saved lives but also contributed to ending Ethiopia’s decades-long civil war. In recognition of his achievements in the Horn of Africa, President Bush awarded Senator Boschwitz the prestigious Citizen’s Medal during a White House Rose Garden ceremony in June 1991.

Senator Boschwitz attended Johns Hopkins University and earned his law degree from New York University. 


Over his career, he has served on the boards of numerous organizations, including the Chicago Mercantile Exchange, American Cancer Society, Twin City Federal Financial Corporation, American-Israeli Public Affairs Committee (AIPAC), IDT Corporation, and Friends of the World Food Program. He has also served on the Board of Directors of the Jewish Institute for National Security Affairs, was a long-standing AIPAC Board Member, and is a member of the Council on Foreign Relations.


Copyright © 2026 Superbug Treatments - The Future of Medicine? - All Rights Reserved.     

FULL DISCLOSURE: This website is provided for informational and educational purposes only. It does not constitute an offer to sell securities, a solicitation of interest in any securities offering, medical advice, or investment advice. Certain statements in this article may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties that could cause actual results to differ materially, including but not limited to: failure of in vivo scientific validation, adverse FDA classification or pathway decisions, inability to secure development financing, unforeseen competitive developments, regulatory changes, and loss of key inventor knowledge. The antimicrobial applications discussed here are investigational and are not FDA-cleared for antimicrobial indications. As of the date of publication, no legal entity has been formed or identified for purposes of any securities offering related to this technology. Any future financing, if any, would be conducted only through formal offering materials and in compliance with applicable federal and state securities laws. Do not rely on this content for investment, legal, or medical decisions.

  • Articles

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept